Duration of the protection of an E2 subunit marker vaccine against classical swine fever after a single vaccination

被引:66
|
作者
de Smit, AJ [1 ]
Bouma, A [1 ]
de Kluijver, EP [1 ]
Terpstra, C [1 ]
Moormann, RJM [1 ]
机构
[1] Inst Anim Sci & Hlth ID Lelystad, Dept Mammalian Virol, NL-8200 AB Lelystad, Netherlands
关键词
classical swine fever virus; marker vaccine; duration of protection;
D O I
10.1016/S0378-1135(00)00306-0
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The period during which pigs are protected after vaccination is important for the successful usage of a marker vaccine against classical swine fever virus (CSFV) in an eradication programme. In four animal experiments with different vaccination-challenge intervals we determined the duration of protection of an E2 subunit marker vaccine in pigs after a single vaccination. Unvaccinated pigs were included in each group to detect transmission of the challenge virus. Three groups of six pigs were vaccinated once and subsequently inoculated with the virulent CSFV strain Brescia after a vaccination-challenge interval of 3, 51/2, 6 or 13 months. All vaccinated pigs, 16 out of 18, with neutralising antibodies against CSFV at the moment of challenge, 3, 51/2, 6 or 13 months later, survived, whereas unvaccinated control pigs died from acute CSF or were killed being moribund. A proportion of the vaccinated pigs did however develop fever or cytopenia after challenge and two vaccinated pigs were viremic after challenge. Virus transmission of vaccinated and challenged pigs to unvaccinated sentinel pigs did not occur in groups of pigs which were challenged 3 or 6 months after a single vaccination. Two out of eight vaccinated pigs that were found negative for CSFV neutralising antibody at 13 months after vaccination died after subsequent challenge. The findings in this study demonstrate that pigs can be protected against a lethal challenge of CSFV for up to 13 months after a single vaccination with an E2 subunit marker vaccine. (C) 2001 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:307 / 317
页数:11
相关论文
共 50 条
  • [1] Prevention of transplacental transmission of moderate-virulent classical swine fever virus after single or double vaccination with an E2 subunit vaccine
    de Smit, AJ
    Bouma, A
    de Kluijver, EP
    Terpstra, C
    Moormann, RJM
    [J]. VETERINARY QUARTERLY, 2000, 22 (03) : 150 - 153
  • [2] A Novel E2 Glycoprotein Subunit Marker Vaccine Produced in Plant Is Able to Prevent Classical Swine Fever Virus Vertical Transmission after Double Vaccination
    Park, Youngmin
    Oh, Yeonsu
    Wang, Miaomiao
    Ganges, Llilianne
    Bohorquez, Jose Alejandro
    Park, Soohong
    Gu, Sungmin
    Park, Jungae
    Lee, Sangmin
    Kim, Jongkook
    Sohn, Eun-Ju
    [J]. VACCINES, 2021, 9 (05)
  • [3] IMMUNOGLOBULINS IN PIGS VACCINATED WITH A SUBUNIT E2 AND AN ATTENUATED C STRAIN VACCINE AGAINST CLASSICAL SWINE FEVER
    Terzic, Svjetlana
    Bilandzic, Nina
    Jemersic, Lorena
    Logomerac, Vesna
    Cvetnic, Z.
    Sandor, Ksenija
    Orsolic, Nada
    Valpotic, I
    [J]. ACTA VETERINARIA-BEOGRAD, 2009, 59 (5-6): : 489 - 501
  • [4] Efficiency Comparison of a Novel E2 Subunit Vaccine and a Classic C-Strain Vaccine against Classical Swine Fever
    Zhou, Pei
    Huang, Junming
    Li, Yanchao
    Chen, Hui
    Wu, Yidan
    Fu, Xueying
    Hao, Xiangqi
    Li, Qi
    Zeng, Rongyu
    Zhang, Guihong
    [J]. VETERINARY SCIENCES, 2021, 8 (08)
  • [5] Efficacy and stability of a subunit vaccine based on glycoprotein E2 of classical swine fever virus
    Bouma, A
    de Smit, AJ
    de Kluijver, EP
    Terpstra, C
    Moormann, RJM
    [J]. VETERINARY MICROBIOLOGY, 1999, 66 (02) : 101 - 114
  • [6] An experimental infection with classical swine fever in E2 subunit marker-vaccine vaccinated and in non-vaccinated pigs
    Dewulf, J
    Laevens, H
    Koenen, F
    Vanderhallen, H
    Mintiens, K
    Deluyker, H
    de Kruif, A
    [J]. VACCINE, 2000, 19 (4-5) : 475 - 482
  • [7] Commercial E2 subunit vaccine provides full protection to pigs against lethal challenge with 4 strains of classical swine fever virus genotype 2
    Gong, Wenjie
    Li, Junhui
    Wang, Zunbao
    Sun, Jiumeng
    Mi, Shijiang
    Xu, Jialun
    Cao, Jian
    Hou, Yuzhen
    Wang, Danyang
    Huo, Xinliang
    Sun, Yanjun
    Wang, Pengjiang
    Yuan, Ke
    Gao, Yangyi
    Zhou, Xubin
    He, Sun
    Tu, Changchun
    [J]. VETERINARY MICROBIOLOGY, 2019, 237
  • [8] Towards licensing of CP7_E2alf as marker vaccine against classical swine fever-Duration of immunity
    Gabriel, Claudia
    Blome, Sandra
    Urniza, Alicia
    Juanola, Sandra
    Koenen, Frank
    Beer, Martin
    [J]. VACCINE, 2012, 30 (19) : 2928 - 2936
  • [9] Yeast expressed classical swine fever E2 subunit vaccine candidate provides complete protection against lethal challenge infection and prevents horizontal virus transmission
    Lin, Guang-Jan
    Deng, Ming-Chung
    Chen, Zeng-Weng
    Liu, Ting-Yu
    Wu, Ching-Wei
    Cheng, Chih-Yuan
    Chien, Maw-Sheng
    Huang, Chienjin
    [J]. VACCINE, 2012, 30 (13) : 2336 - 2341
  • [10] Vaccination with a single dose of a recombinant porcine adenovirus expressing the classical swine fever virus gp55 (E2) gene protects pigs against classical swine fever
    Hammond, JM
    McCoy, RJ
    Jansen, ES
    Morrissy, CJ
    Hodgson, ALM
    Johnson, MA
    [J]. VACCINE, 2000, 18 (11-12) : 1040 - 1050